FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3165440170> ?p ?o ?g. }

• W3165440170 abstract "Abstract Background Smart nanoscale drug delivery systems that target acidic tumor microenvironments (TME) could offer controlled release of drugs and modulate the hypoxic TME to enhance cancer therapy. The majority of previously reported MnO 2 nanostructures are nanoparticles, nanosheets, or nanocomposites incorporated with other types of nanoparticles, which may not offer the most effective method for drug loading or for the controlled release of therapeutic payloads. Previous studies have designed MnO 2 nanoshells that achieve tumor-specific and enhanced combination therapy for localized advanced cancer. However, the therapeutic effect of MnO 2 nanoshells on metastatic cancer is still uncertain. Result Here, intelligent “theranostic” platforms were synthesized based on hollow mesoporous MnO 2 (H-MnO 2 ) nanoshells that were loaded with chemotherapy agents docetaxel and cisplatin (TP) to form H-MnO 2 -PEG/TP nanoshells, which were designed to alleviate tumor hypoxia, attenuate angiogenesis, trigger the dissolution of Mn 2+ , and synergize the efficacy of first-class anticancer chemotherapy. The obtained H-MnO 2 -PEG/TP nanoshells decomposed in the acidic TME, releasing the loaded drugs (TP) and simultaneously attenuated tumor hypoxia and hypoxia-inducible factor-1α (HIF-1α) expression by inducing endogenous tumor hydrogen peroxide (H 2 O 2 ) decomposition. In vitro experiments showed that compared with the control group, the proliferation, colony formation and migration ability of CAL27 and SCC7 cells were significantly reduced in H-MnO 2 -PEG/TP group, while cell apoptosis was enhanced, and the expression of hypoxia-inducible factor-1α(HIF-1α) was down-regulated. In vivo experiments showed that tumor to normal organ uptake ratio (T/N ratio) of mice in H-MnO 2 -PEG/TP group was significantly higher than that in TP group alone (without the nanoparticle), and tumor growth was partially delayed. In the H-MnO 2 -PEG/TP treatment group, HE staining showed that most of the tumor cells were severely damaged, and TUNEL assay showed cell apoptosis was up-regulated. He staining of renal and liver sections showed no obvious fibrosis, necrosis or hypertrophy, indicating good biosafety. Fluorescence staining showed that HIF-1α expression was decreased, suggesting that the accumulation of MnO 2 in the tumor caused the decomposition of H 2 O 2 into O 2 and alleviated the hypoxia of the tumor. Conclusion In conclusion, a remarkable in vivo and in vitro synergistic therapeutic effect is achieved through the combination of TP chemotherapy, which simultaneously triggered a series of antiangiogenic and oxidative antitumor reactions. Graphic abstract" @default.
• W3165440170 created "2021-06-07" @default.
• W3165440170 creator A5003067901 @default.
• W3165440170 creator A5010388094 @default.
• W3165440170 creator A5012562375 @default.
• W3165440170 creator A5021980658 @default.
• W3165440170 creator A5028536689 @default.
• W3165440170 creator A5039962835 @default.
• W3165440170 creator A5049404345 @default.
• W3165440170 creator A5075537675 @default.
• W3165440170 creator A5081244781 @default.
• W3165440170 creator A5083408391 @default.
• W3165440170 creator A5085434182 @default.
• W3165440170 creator A5087630822 @default.
• W3165440170 date "2021-05-26" @default.
• W3165440170 modified "2023-10-17" @default.
• W3165440170 title "Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma" @default.
• W3165440170 cites W1970424743 @default.
• W3165440170 cites W1971963087 @default.
• W3165440170 cites W1989941143 @default.
• W3165440170 cites W2043836738 @default.
• W3165440170 cites W2049820772 @default.
• W3165440170 cites W2073390395 @default.
• W3165440170 cites W2082590328 @default.
• W3165440170 cites W2121855058 @default.
• W3165440170 cites W2122812296 @default.
• W3165440170 cites W2125209555 @default.
• W3165440170 cites W2128397866 @default.
• W3165440170 cites W2151371881 @default.
• W3165440170 cites W2331772460 @default.
• W3165440170 cites W2338362917 @default.
• W3165440170 cites W2342432125 @default.
• W3165440170 cites W2408837317 @default.
• W3165440170 cites W2413193118 @default.
• W3165440170 cites W2478251420 @default.
• W3165440170 cites W2518161542 @default.
• W3165440170 cites W2567220532 @default.
• W3165440170 cites W2764028271 @default.
• W3165440170 cites W2771428152 @default.
• W3165440170 cites W2789637558 @default.
• W3165440170 cites W2790069485 @default.
• W3165440170 cites W2793503277 @default.
• W3165440170 cites W2806940039 @default.
• W3165440170 cites W2908755714 @default.
• W3165440170 cites W2945080753 @default.
• W3165440170 cites W2945806284 @default.
• W3165440170 cites W2968531020 @default.
• W3165440170 cites W2980082933 @default.
• W3165440170 cites W2985055119 @default.
• W3165440170 cites W2987284967 @default.
• W3165440170 cites W2993396470 @default.
• W3165440170 cites W2995340618 @default.
• W3165440170 cites W3025246877 @default.
• W3165440170 cites W3033746124 @default.
• W3165440170 cites W3082231031 @default.
• W3165440170 cites W3083897168 @default.
• W3165440170 cites W3087985475 @default.
• W3165440170 cites W3088553558 @default.
• W3165440170 cites W3092227780 @default.
• W3165440170 doi "https://doi.org/10.1186/s12951-021-00901-9" @default.
• W3165440170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8157461" @default.
• W3165440170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34039370" @default.
• W3165440170 hasPublicationYear "2021" @default.
• W3165440170 type Work @default.
• W3165440170 sameAs 3165440170 @default.
• W3165440170 citedByCount "20" @default.
• W3165440170 countsByYear W31654401702021 @default.
• W3165440170 countsByYear W31654401702022 @default.
• W3165440170 countsByYear W31654401702023 @default.
• W3165440170 crossrefType "journal-article" @default.
• W3165440170 hasAuthorship W3165440170A5003067901 @default.
• W3165440170 hasAuthorship W3165440170A5010388094 @default.
• W3165440170 hasAuthorship W3165440170A5012562375 @default.
• W3165440170 hasAuthorship W3165440170A5021980658 @default.
• W3165440170 hasAuthorship W3165440170A5028536689 @default.
• W3165440170 hasAuthorship W3165440170A5039962835 @default.
• W3165440170 hasAuthorship W3165440170A5049404345 @default.
• W3165440170 hasAuthorship W3165440170A5075537675 @default.
• W3165440170 hasAuthorship W3165440170A5081244781 @default.
• W3165440170 hasAuthorship W3165440170A5083408391 @default.
• W3165440170 hasAuthorship W3165440170A5085434182 @default.
• W3165440170 hasAuthorship W3165440170A5087630822 @default.
• W3165440170 hasBestOaLocation W31654401701 @default.
• W3165440170 hasConcept C121608353 @default.
• W3165440170 hasConcept C12554922 @default.
• W3165440170 hasConcept C126322002 @default.
• W3165440170 hasConcept C150903083 @default.
• W3165440170 hasConcept C155672457 @default.
• W3165440170 hasConcept C171250308 @default.
• W3165440170 hasConcept C178790620 @default.
• W3165440170 hasConcept C185592680 @default.
• W3165440170 hasConcept C190283241 @default.
• W3165440170 hasConcept C192562407 @default.
• W3165440170 hasConcept C207001950 @default.
• W3165440170 hasConcept C2776107976 @default.
• W3165440170 hasConcept C2776694085 @default.
• W3165440170 hasConcept C2779081379 @default.
• W3165440170 hasConcept C2779820397 @default.
• W3165440170 hasConcept C2780394083 @default.
• W3165440170 hasConcept C3020616263 @default.

• next